TR201200211A2 - Risedronat içeren farmasötik granüller. - Google Patents
Risedronat içeren farmasötik granüller.Info
- Publication number
- TR201200211A2 TR201200211A2 TR2012/00211A TR201200211A TR201200211A2 TR 201200211 A2 TR201200211 A2 TR 201200211A2 TR 2012/00211 A TR2012/00211 A TR 2012/00211A TR 201200211 A TR201200211 A TR 201200211A TR 201200211 A2 TR201200211 A2 TR 201200211A2
- Authority
- TR
- Turkey
- Prior art keywords
- granules containing
- containing risedronate
- pharmaceutical granules
- risedronate
- pharmaceutical
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/0002—Galenical forms characterised by the drug release technique; Application systems commanded by energy
- A61K9/0007—Effervescent
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/66—Phosphorus compounds
- A61K31/675—Phosphorus compounds having nitrogen as a ring hetero atom, e.g. pyridoxal phosphate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/14—Particulate form, e.g. powders, Processes for size reducing of pure drugs or the resulting products, Pure drug nanoparticles
- A61K9/16—Agglomerates; Granulates; Microbeadlets ; Microspheres; Pellets; Solid products obtained by spray drying, spray freeze drying, spray congealing,(multiple) emulsion solvent evaporation or extraction
- A61K9/1605—Excipients; Inactive ingredients
- A61K9/1611—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K9/00—Medicinal preparations characterised by special physical form
- A61K9/20—Pills, tablets, discs, rods
- A61K9/2004—Excipients; Inactive ingredients
- A61K9/2009—Inorganic compounds
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
Landscapes
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Life Sciences & Earth Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Epidemiology (AREA)
- Inorganic Chemistry (AREA)
- Physical Education & Sports Medicine (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicinal Preparation (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Packages (AREA)
- Steroid Compounds (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Abstract
Mevcut buluş kemik erimesi ve ilişkili hastalıkların önlenmesinde ve tedavisinde kullanılmak üzere risedronat içeren farmasötik formülasyonlara ilişkindir.
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2012/00211A TR201200211A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren farmasötik granüller. |
Applications Claiming Priority (2)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
TR2011/00149A TR201100149A2 (tr) | 2011-01-06 | 2011-01-06 | Geliştirilmiş risedronat formülasyonu. |
TR2012/00211A TR201200211A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren farmasötik granüller. |
Publications (1)
Publication Number | Publication Date |
---|---|
TR201200211A2 true TR201200211A2 (tr) | 2012-07-23 |
Family
ID=45787321
Family Applications (4)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2011/00149A TR201100149A2 (tr) | 2011-01-06 | 2011-01-06 | Geliştirilmiş risedronat formülasyonu. |
TR2012/00211A TR201200211A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren farmasötik granüller. |
TR2012/00212A TR201200212A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren geliştirilmiş formülasyonlar. |
TR2012/00213A TR201200213A2 (tr) | 2011-01-06 | 2012-01-06 | Kombine dozaj formları. |
Family Applications Before (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2011/00149A TR201100149A2 (tr) | 2011-01-06 | 2011-01-06 | Geliştirilmiş risedronat formülasyonu. |
Family Applications After (2)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
TR2012/00212A TR201200212A2 (tr) | 2011-01-06 | 2012-01-06 | Risedronat içeren geliştirilmiş formülasyonlar. |
TR2012/00213A TR201200213A2 (tr) | 2011-01-06 | 2012-01-06 | Kombine dozaj formları. |
Country Status (3)
Country | Link |
---|---|
EP (1) | EP2661258B1 (tr) |
TR (4) | TR201100149A2 (tr) |
WO (1) | WO2012093980A1 (tr) |
Family Cites Families (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
IL77243A (en) | 1984-12-21 | 1996-11-14 | Procter & Gamble | Pharmaceutical compositions containing geminal diphosphonic acid compounds and certain such novel compounds |
TR200900878A2 (tr) * | 2009-02-05 | 2010-08-23 | Bi̇lgi̇ç Mahmut | Tek bir dozaj formunda kombine edilen farmasötik formülasyonlar |
-
2011
- 2011-01-06 TR TR2011/00149A patent/TR201100149A2/tr unknown
-
2012
- 2012-01-06 WO PCT/TR2012/000011 patent/WO2012093980A1/en active Application Filing
- 2012-01-06 TR TR2012/00211A patent/TR201200211A2/tr unknown
- 2012-01-06 TR TR2012/00212A patent/TR201200212A2/tr unknown
- 2012-01-06 TR TR2012/00213A patent/TR201200213A2/tr unknown
- 2012-01-06 EP EP12706950.8A patent/EP2661258B1/en active Active
Also Published As
Publication number | Publication date |
---|---|
TR201200212A2 (tr) | 2012-07-23 |
TR201200213A2 (tr) | 2012-07-23 |
EP2661258B1 (en) | 2016-04-27 |
TR201100149A2 (tr) | 2012-07-23 |
WO2012093980A1 (en) | 2012-07-12 |
EP2661258A1 (en) | 2013-11-13 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
PH12017501306A1 (en) | Inhibitors of histone demethylases | |
EA201590165A1 (ru) | Сдерживающие злоупотребление фармацевтические композиции для контролируемого высвобождения | |
IN2014MN00948A (tr) | ||
TN2015000278A1 (en) | Autotaxin inhibitors | |
TN2012000465A1 (en) | Derivatives of 1-amino-2-cyclopropylethylboronic acid | |
PH12015500274B1 (en) | Alkylpyrimidine derivatives for the treatment of viral infections and further diseases | |
BR112015010663A2 (pt) | formas de dosagem de ruxolitinib de liberação sustentada | |
TW201129382A (en) | Antibody formulation and therapeutic regimens | |
IN2014MN02069A (tr) | ||
EA201991484A1 (ru) | Лекарственные формы энзалутамида | |
IN2014DN06501A (tr) | ||
IN2014MN00987A (tr) | ||
IN2014MN00986A (tr) | ||
MX2013011908A (es) | Composiciones y usos terapeuticos de inhibidores de cinasa epsilon relacionados con cinasa i-kappa b (ikk) y cinasa 1 de union tank. | |
HN2012000023A (es) | Compuestos y composiciones para el tratamiento de enfermedades parasitarias | |
EA201300471A1 (ru) | Замещенные 6-аминоникотинамиды в качестве модуляторов kcnq2/3 | |
EA201690039A1 (ru) | Ингибиторы rorc2 и способы их применения | |
EA201201296A1 (ru) | Способы лечения диабетических язв стопы | |
PH12014502623A1 (en) | Difluoro-hexahydro-cyclopentaoxazinyls and difluoro-hexahydro-benzooxazinyls as bace1 inhibitors | |
TR201004464A2 (tr) | Kemik erimesi için formülasyon. | |
CY1116158T1 (el) | Υποκατεστημενα 2-οξο- και 2-θειοξο-διυδροκινολινο-3-καρβοξαμιδια σαν διαμορφωτες kcnq2/3 | |
IN2014DN07913A (tr) | ||
MX2013010367A (es) | Composiciones y metodos para la terapia y diagnostico de influenza. | |
IN2014DN03010A (tr) | ||
TR201100151A2 (tr) | İbandronate formülasyonu. |